Windsor Sherrill to Aromatase Inhibitors
This is a "connection" page, showing publications Windsor Sherrill has written about Aromatase Inhibitors.
Connection Strength
0.081
-
Factors associated with longer endocrine therapy use by South Carolina Medicaid-insured breast cancer survivors. J Oncol Pharm Pract. 2020 Jan; 26(1):36-42.
Score: 0.042
-
Endocrine therapy use in the twenty-first century: usage rates and temporal trends illustrate opportunities for improvement for South Carolina Medicaid women. Breast Cancer Res Treat. 2018 Oct; 171(3):759-765.
Score: 0.040